Suchergebnisse - (Standardsuche:issn:"1568-0096" OR issn:"1873-5576")

PubPharm (2.322)

2311

Oncogene-blocking therapies : new insights from conditional mouse tumor models

enthalten in: Current cancer drug targets | 2006

von Hengstler, J. | Bockamp, E. | Hermes, M. | +15

2312

Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention

enthalten in: Current cancer drug targets | 2006

von Chen, X. | Sood, S. | Yang, C. | +2

2313

Protein kinases as drug targets in cancer

enthalten in: Current cancer drug targets | 2006

von Arslan, M. | Kutuk, O. | Basaga, H.

2314

Adrenomedullin : a tumor progression factor via angiogenic control

enthalten in: Current cancer drug targets | 2006

von Nakamura, M. | Han, B. | Nunobiki, O. | +1

2315

Knowledge of epigenetic influence for prostate cancer therapy

enthalten in: Current cancer drug targets | 2006

von Watanabe, M. | Takagi, A. | Matsuzaki, T. | +4

2316

Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers

enthalten in: Current cancer drug targets | 2006

von Waterhouse, D. | Gelmon, K. | Klasa, R. | +14

ErratumIn: Curr Cancer Drug Targets. 2006 Dec;6(8):753 Zhang, YZ [corrected to Wang, YZ]

2317

Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy

enthalten in: Current cancer drug targets | 2006

von Becker, T. | Dziadek, S. | Wittrock, S. | +1

2318

Protein tyrosine phosphatases, new targets for cancer therapy

enthalten in: Current cancer drug targets | 2006

von Easty, D. | Gallagher, W. | Bennett, D.

2319

Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS) : future molecular therapeutic directions for MDS

enthalten in: Current cancer drug targets | 2006

von Harada, H. | Harada, Y. | Kimura, A.

2320

Current cancer drug targets

Erschienen: Hilversum [u.a.], Bentham Science Publ., 2001-